FDA Inspection 821318 — Quasar Bio-Tech, Inc.

Quasar Bio-Tech, Inc. — FEI 3006182559

The FDA completed an inspection of Quasar Bio-Tech, Inc. on March 6, 2013 in Yorba Linda, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 6, 2013
Fiscal Year
2013
Product Type
Devices
Project Area
Compliance: Devices
Location
Yorba Linda, CA (United States)

Citations

IDCFRDescription
310221 CFR 820.30(h)Design transfer - Lack of or inadequate procedures
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
337221 CFR 820.198(d)Records of MDR Investigation
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation